DDX3 exerts oncogenic roles in glioblastoma (160, 161), meningioma (162), Ewing sarcoma (68), prostate cancer (134), chronic lymphocytic leukemia (163, 164), pancreatic ductal adenocarcinoma (165), and gallbladder cancer (126). Here, DDX3X is linked to glioblastoma.